We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+8.96%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.6B
AUM Growth
+$1.15B
(+1.6%)
Cap. Flow
-$3.6B
Cap. Flow
% of AUM
-4.89%
Top 10 Holdings %
Top 10 Hldgs %
20.8%
Holding
3,102
New
50
Increased
790
Reduced
2,114
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$38.7M |
| 2 |
International Flavors & Fragrances
IFF
|
+$27.4M |
| 3 |
Neurocrine Biosciences
NBIX
|
+$14.7M |
| 4 |
ConocoPhillips
COP
|
+$14.5M |
| 5 |
Royalty Pharma
RPRX
|
+$9.46M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$269M |
| 2 |
Microsoft
MSFT
|
+$172M |
| 3 |
Amazon
AMZN
|
+$114M |
| 4 |
Walt Disney
DIS
|
+$62.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$61.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.61% |
| 2 | Financials | 14.26% |
| 3 | Healthcare | 12.86% |
| 4 | Consumer Discretionary | 12.27% |
| 5 | Industrials | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NGM
2276
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $828K | ﹤0.01% |
28,492
-860
| -3% | -$24.1K |
|
|
CNST
2277
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $828K | ﹤0.01% |
35,394
-3,156
| -8% | -$95.6K |
|
|
ZYXI
2278
DELISTED
Zynex
ZYXI
| $826K | ﹤0.01% |
59,512
+275
| +0.5% | +$4.2K |
|
|
AERI
2279
DELISTED
Aerie Pharmaceuticals
AERI
| $825K | ﹤0.01% |
46,182
-4,668
| -9% | -$80.6K |
|
2280
First Community Bankshares
FCBC
$911M
| $822K | ﹤0.01% |
27,402
-1,545
| -5% | -$39.4K |
|
|
FLIC
2281
DELISTED
First of Long Island Corp
FLIC
| $821K | ﹤0.01% |
38,627
-2,154
| -5% | -$40.8K |
|
|
SWI
2282
DELISTED
SolarWinds Corporation Common Stock
SWI
| $815K | ﹤0.01% |
44,280
-1,104
| -2% | -$19K |
|
2283
Barrett Business Services
BBSI
$804M
| $814K | ﹤0.01% |
47,280
-2,280
| -5% | -$39.8K |
|
|
TCRR
2284
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $814K | ﹤0.01% |
36,874
-10
| -0% | -$273 |
|
|
VRS
2285
DELISTED
Verso Corporation
VRS
| $814K | ﹤0.01% |
55,819
-3,205
| -5% | -$42.1K |
|
2286
Nordic American Tanker
NAT
$1.37B
| $810K | ﹤0.01% |
249,093
-10,224
| -4% | -$33K |
|
2287
Waterstone Financial
WSBF
$375M
| $805K | ﹤0.01% |
39,445
-3,347
| -8% | -$66.2K |
|
|
AFMD
2288
DELISTED
Affimed
AFMD
| $801K | ﹤0.01% |
10,130
+2,095
| +26% | +$136K |
|
|
LORL
2289
DELISTED
Loral Space and Communications, Inc.
LORL
| $799K | ﹤0.01% |
21,223
-1,100
| -5% | -$39.2K |
|
2290
Daktronics
DAKT
$1.04B
| $797K | ﹤0.01% |
127,112
+1,844
| +1% | +$10.4K |
|
2291
AnaptysBio
ANAB
$1.68B
| $796K | ﹤0.01% |
36,939
-2,185
| -6% | -$55.1K |
|
|
MNRL
2292
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
| $796K | ﹤0.01% |
54,391
-1,655
| -3% | -$24K |
|
2293
Titan Machinery
TITN
$445M
| $793K | ﹤0.01% |
31,089
-2,199
| -7% | -$52.9K |
|
2294
Vera Bradley
VRA
$98.7M
| $790K | ﹤0.01% |
78,193
+2,575
| +3% | +$24.2K |
|
|
LTRPA
2295
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $784K | ﹤0.01% |
122,904
-4,911
| -4% | -$26.5K |
|
2296
Sportsman's Warehouse
SPWH
$46M
| $781K | ﹤0.01% |
45,313
-5,435
| -11% | -$94.6K |
|
2297
CVR Energy
CVI
$3.13B
| $780K | ﹤0.01% |
40,671
-3,582
| -8% | -$72.8K |
|
2298
Costamare
CMRE
$1.77B
| $778K | ﹤0.01% |
80,891
-4,526
| -5% | -$42.2K |
|
2299
Expro Ltd
XPRO
$1.91B
| $778K | ﹤0.01% |
36,503
-1,682
| -4% | -$36.6K |
|
2300
StepStone Group
STEP
$3.82B
| $774K | ﹤0.01% |
21,944
+170
| +0.8% | +$5.99K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2021 Portfolio in Review
As of Q1 2021, RhumbLine Advisers held 3,102 positions worth $73.6B, up 1.6% from $72.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
RhumbLine Advisers withdrew a net $3.6B in Q1 2021, closing 100 positions and reducing 2,114 holdings. Its most notable exit was Tiffany & Co., an estimated $26.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
Against the trend, RhumbLine Advisers opened a new position in NXP Semiconductors worth $42.7M.
- RhumbLine Advisers's largest Q1 2021 buy was NXP Semiconductors: 211,843 shares worth $42.7M.
- RhumbLine Advisers added most to International Flavors & Fragrances in Q1 2021, an estimated $27.4M increase.
- RhumbLine Advisers's biggest Q1 2021 reduction was Apple, cutting an estimated $269M.
- RhumbLine Advisers fully exited Tiffany & Co. in Q1 2021, selling an estimated $26.8M.
- RhumbLine Advisers's ten largest holdings make up 21% of its $73.6B portfolio in Q1 2021.
- RhumbLine Advisers opened 50 new positions and closed 100 in Q1 2021.
- RhumbLine Advisers's portfolio value rose 1.6% quarter-over-quarter to $73.6B.
Based on RhumbLine Advisers's 13F filing for Q1 2021, filed 6 May 2021.